Dynamics of Schistosoma haematobium egg output and associated infection parameters following treatment with praziquantel in school-aged children
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-3305
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Dynamics of Schistosoma haematobium egg output and associated infection parameters following treatment with praziquantel in school-aged children ; volume:5 ; number:1 ; day:21 ; month:12 ; year:2012 ; pages:1-10 ; date:12.2012
Parasites & vectors ; 5, Heft 1 (21.12.2012), 1-10, 12.2012
- Creator
-
Stete, Katarina
Krauth, Stefanie J.
Coulibaly, Jean T.
Knopp, Stefanie
Hattendorf, Jan
Müller, Ivan
Lohourignon, Laurent K.
Kern, Winfried V.
N’Goran, Eliézer K.
Utzinger, Jürg
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/1756-3305-5-298
- URN
-
urn:nbn:de:101:1-2021080718522994211212
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:57 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Stete, Katarina
- Krauth, Stefanie J.
- Coulibaly, Jean T.
- Knopp, Stefanie
- Hattendorf, Jan
- Müller, Ivan
- Lohourignon, Laurent K.
- Kern, Winfried V.
- N’Goran, Eliézer K.
- Utzinger, Jürg
- SpringerLink (Online service)
Other Objects (12)
Schistosoma haematobium infections among schoolchildren in central Sudan one year after treatment with praziquantel
Safety and Efficacy of Praziquantel in Pregnant Women Infected with Schistosoma haematobium in Lambaréné, Gabon
Efficacy and safety of ascending doses of praziquantel against Schistosoma haematobium infection in preschool-aged and school-aged children: a single-blind randomised controlled trial
Schistosoma haematobium infection morbidity, praziquantel effectiveness and reinfection rate among children and young adults in Gabon
Dynamics of Schistosoma haematobium egg output and associated infection parameters following treatment with praziquantel in schoolchildren in South Côte d'Ivoire : = Dynamik der Ausscheidung von Schistosoma haematobium Eiern und der assoziierten Infektparameter nach Behandlung mit Praziquantel bei Schulkindern im Süden der Côte d'Ivoire
CRISPR-assisted test for Schistosoma haematobium
In vitro and in vivo activity of R- and S- praziquantel enantiomers and the main human metabolite trans-4-hydroxy-praziquantel against Schistosoma haematobium
Correction to: Schistosoma haematobium infection morbidity, praziquantel effectiveness and reinfection rate among children and young adults in Gabon
Prevalence and seasonal transmission of Schistosoma haematobium infection among school-aged children in Kaedi town, southern Mauritania
Three monthly doses of 60 mg/kg praziquantel for Schistosoma haematobium infection is a safe and effective treatment regimen
Praziquantel is an effective drug for the treatment of Schistosoma Mansoni infection among school-aged children in Northwest Ethiopia
Sonomorphometrische Untersuchungen der Nieren, Leber und Milz bei kongolesischen Patienten mit einer Schistosoma haematobium Infektion vor und nach Therapie mit Praziquantel
Schistosoma haematobium infections among schoolchildren in central Sudan one year after treatment with praziquantel
Safety and Efficacy of Praziquantel in Pregnant Women Infected with Schistosoma haematobium in Lambaréné, Gabon
Efficacy and safety of ascending doses of praziquantel against Schistosoma haematobium infection in preschool-aged and school-aged children: a single-blind randomised controlled trial
Schistosoma haematobium infection morbidity, praziquantel effectiveness and reinfection rate among children and young adults in Gabon
Dynamics of Schistosoma haematobium egg output and associated infection parameters following treatment with praziquantel in schoolchildren in South Côte d'Ivoire : = Dynamik der Ausscheidung von Schistosoma haematobium Eiern und der assoziierten Infektparameter nach Behandlung mit Praziquantel bei Schulkindern im Süden der Côte d'Ivoire
CRISPR-assisted test for Schistosoma haematobium
In vitro and in vivo activity of R- and S- praziquantel enantiomers and the main human metabolite trans-4-hydroxy-praziquantel against Schistosoma haematobium
Correction to: Schistosoma haematobium infection morbidity, praziquantel effectiveness and reinfection rate among children and young adults in Gabon
Prevalence and seasonal transmission of Schistosoma haematobium infection among school-aged children in Kaedi town, southern Mauritania
Three monthly doses of 60 mg/kg praziquantel for Schistosoma haematobium infection is a safe and effective treatment regimen
Praziquantel is an effective drug for the treatment of Schistosoma Mansoni infection among school-aged children in Northwest Ethiopia
Sonomorphometrische Untersuchungen der Nieren, Leber und Milz bei kongolesischen Patienten mit einer Schistosoma haematobium Infektion vor und nach Therapie mit Praziquantel
Schistosoma haematobium infections among schoolchildren in central Sudan one year after treatment with praziquantel
Safety and Efficacy of Praziquantel in Pregnant Women Infected with Schistosoma haematobium in Lambaréné, Gabon
Efficacy and safety of ascending doses of praziquantel against Schistosoma haematobium infection in preschool-aged and school-aged children: a single-blind randomised controlled trial
Schistosoma haematobium infection morbidity, praziquantel effectiveness and reinfection rate among children and young adults in Gabon
Dynamics of Schistosoma haematobium egg output and associated infection parameters following treatment with praziquantel in schoolchildren in South Côte d'Ivoire : = Dynamik der Ausscheidung von Schistosoma haematobium Eiern und der assoziierten Infektparameter nach Behandlung mit Praziquantel bei Schulkindern im Süden der Côte d'Ivoire
CRISPR-assisted test for Schistosoma haematobium
In vitro and in vivo activity of R- and S- praziquantel enantiomers and the main human metabolite trans-4-hydroxy-praziquantel against Schistosoma haematobium
Correction to: Schistosoma haematobium infection morbidity, praziquantel effectiveness and reinfection rate among children and young adults in Gabon
Prevalence and seasonal transmission of Schistosoma haematobium infection among school-aged children in Kaedi town, southern Mauritania
Three monthly doses of 60 mg/kg praziquantel for Schistosoma haematobium infection is a safe and effective treatment regimen
Praziquantel is an effective drug for the treatment of Schistosoma Mansoni infection among school-aged children in Northwest Ethiopia